Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Other Gross PP&E Adjustments: 2011-2019

Historic Other Gross PP&E Adjustments for EyePoint Pharmaceuticals (EYPT) over the last 5 years, with Mar 2019 value amounting to -$3.4 million.

  • EyePoint Pharmaceuticals' Other Gross PP&E Adjustments fell 164.66% to -$3.4 million in Q1 2019 from the same period last year, while for Mar 2019 it was -$3.7 million, marking a year-over-year decrease of 78.05%. This contributed to the annual value of -$20,000 for FY2018, which is 109.57% down from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at -$3.4 million for Q1 2019, which was down 923.54% from $412,000 recorded in Q4 2018.
  • Over the past 5 years, EyePoint Pharmaceuticals' Other Gross PP&E Adjustments peaked at $1.8 million during Q2 2015, and registered a low of -$3.4 million during Q1 2019.
  • Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$594,000 (2017), whereas its average is -$725,444.
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Other Gross PP&E Adjustments skyrocketed by 169.36% in 2018, and later plummeted by 164.66% in 2019.
  • Over the past 5 years, EyePoint Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at -$342,000 in 2015, then slumped by 98.54% to -$679,000 in 2016, then rose by 12.52% to -$594,000 in 2017, then surged by 169.36% to $412,000 in 2018, then plummeted by 164.66% to -$3.4 million in 2019.
  • Its Other Gross PP&E Adjustments was -$3.4 million in Q1 2019, compared to $412,000 in Q4 2018 and -$722,000 in Q3 2018.